SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001654954-23-012977
Filing Date
2023-10-16
Accepted
2023-10-16 16:18:54
Documents
4
Period of Report
2023-10-12

Document Format Files

Seq Description Document Type Size
1 PRE 14A tenx_pre14a.htm PRE 14A 184608
2 tenx_pre14aimg3.jpg GRAPHIC 10279
3 tenx_pre14aimg4.jpg GRAPHIC 117316
4 tenx_pre14aimg5.jpg GRAPHIC 86331
  Complete submission text file 0001654954-23-012977.txt   480880
Mailing Address 101 GLEN LENNOX DRIVE SUITE 300 CHAPEL HILL NC 27517
Business Address 101 GLEN LENNOX DRIVE SUITE 300 CHAPEL HILL NC 27517 919-855-2100
TENAX THERAPEUTICS, INC. (Filer) CIK: 0000034956 (see all company filings)

IRS No.: 262593535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-34600 | Film No.: 231327527
SIC: 2834 Pharmaceutical Preparations